ArticleNPJ digital medicine2026
Unlocking multi-institutional insights into disease progression with PEAL as a lossless, one-shot federated learning solution.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Multisite analysis of electronic health record (EHR) data presents unique opportunities for studying disease progression in real-world settings. However, privacy concerns, communication costs, and site-level heterogeneity pose significant challenges for analyzing longitudinal data. We introduce PEAL (Privacy-preserving Efficient Aggregation for Longitudinal data), a novel federated learning algorithm for fitting multi-level linear mixed-effects models with spline basis terms for nonlinear temporal trends. PEAL requires only a single-round transfer of summary statistics and produces results identical to using pooled individual participant data. Simulation studies demonstrate that PEAL accurately recovers fixed effects and variance components under realistic multi-level structures. We applied PEAL to real-world longitudinal datasets of systemic sclerosis patients from the Johns Hopkins and University of Pittsburgh Scleroderma Centers. This application shows our algorithm captures reasonable disease trajectories. Overall, PEAL provides a practical solution for distributed research networks studying rare diseases and time-evolving clinical outcomes by enabling lossless, communication-efficient, and privacy-preserving modeling.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.